Cargando…

Gut microbiota: A new target for T2DM prevention and treatment

Type 2 diabetes mellitus (T2DM), one of the fastest growing metabolic diseases, has been characterized by metabolic disorders including hyperglycemia, hyperlipidemia and insulin resistance (IR). In recent years, T2DM has become the fastest growing metabolic disease in the world. Studies have indicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lulu, Zhang, Jiheng, Cheng, Yi, Zhu, Meng, Xiao, Zhifeng, Ruan, Guangcong, Wei, Yanling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402911/ https://www.ncbi.nlm.nih.gov/pubmed/36034447 http://dx.doi.org/10.3389/fendo.2022.958218

Ejemplares similares

Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome
por: Chen, Minjia, et al.
Publicado: (2022)

New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis
por: Xu, Fenghua, et al.
Publicado: (2021)

Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
por: Covasa, Mihai, et al.
Publicado: (2019)

Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules
por: Lv, Linling, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

Cyclocarya paliurus leaves extracts alleviate metabolic phenotypes in Chinese T2DM patients by modulating gut microbiota and metabolites: a clinical randomized controlled trial
por: Peng, Xiaojuan, et al.
Publicado: (2023)

Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
por: Wu, Jiaqiang, et al.
Publicado: (2023)

The critical role of gut microbiota in obesity
por: Cheng, Zilu, et al.
Publicado: (2022)

Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis
por: Lv, Zhuan, et al.
Publicado: (2022)

Mining Gut Microbiota From Bariatric Surgery for MAFLD
por: Wu, Wei-Kai, et al.
Publicado: (2021)

Necroptosis: A new target for prevention of osteoporosis
por: Hu, Xinli, et al.
Publicado: (2022)

Editorial: Microbiota-hormones-gut axis as a therapeutic target for metabolic disorders
por: Abidi, Anouar, et al.
Publicado: (2023)

TNF Signaling Acts Downstream of MiR-322/-503 in Regulating DM1 Myogenesis
por: Li, Meng, et al.
Publicado: (2022)

Editorial: Gut microbiota and gut-associated metabolites in bone health
por: Srivastava, Rupesh K., et al.
Publicado: (2023)

Skeletal muscles and gut microbiota-derived metabolites: novel modulators of adipocyte thermogenesis
por: Tang, Yi, et al.
Publicado: (2023)

Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole
por: Li, Yushan, et al.
Publicado: (2023)

Gut Microbiota and Energy Homeostasis in Fish
por: Butt, Robyn Lisa, et al.
Publicado: (2019)

Altered Gut Microbiota in Children With Hyperuricemia
por: Yuan, Xin, et al.
Publicado: (2022)

Progress in the Study of Colorectal Cancer Caused by Altered Gut Microbiota After Cholecystectomy
por: Ma, Yanpeng, et al.
Publicado: (2022)

RFWD3 Participates in the Occurrence and Development of Colorectal Cancer via E2F1 Transcriptional Regulation of BIRC5
por: Xu, Fenghua, et al.
Publicado: (2021)

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
por: Luo, Jian-Quan, et al.
Publicado: (2023)

Effect of the Chinese New Year Public Holiday on the Glycemic Control of T1DM With Intensive Insulin Therapy
por: Guo, Keyu, et al.
Publicado: (2022)

Impact of Gut Microbiota on Host Glycemic Control
por: Gérard, Céline, et al.
Publicado: (2019)

Gut microbiota is a potential goalkeeper of dyslipidemia
por: Lei, Lirong, et al.
Publicado: (2022)

Bile acids, gut microbiota and metabolic surgery
por: Tu, Jui, et al.
Publicado: (2022)

Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
por: De Filippo, Carlotta, et al.
Publicado: (2023)

Study on the differences of gut microbiota composition between phlegm-dampness syndrome and qi-yin deficiency syndrome in patients with metabolic syndrome
por: Shang, Haonan, et al.
Publicado: (2022)

Effects of Icariin on Modulating Gut Microbiota and Regulating Metabolite Alterations to Prevent Bone Loss in Ovariectomized Rat Model
por: Wang, Shanshan, et al.
Publicado: (2022)

Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
por: Wang, Dongmei, et al.
Publicado: (2022)

Alteration of Gut Microbiota Relates to Metabolic Disorders in Primary Aldosteronism Patients
por: Liu, Yu, et al.
Publicado: (2021)

Vascular Endothelial Function as a Valid Predictor of Variations in Pulmonary Function in T2DM Patients Without Related Complications
por: Tai, He, et al.
Publicado: (2021)

Corrigendum: Effect of the Chinese New Year public holiday on the glycemic control of T1DM with intensive insulin therapy
por: Guo, Keyu, et al.
Publicado: (2022)

Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis
por: Zhou, Liyuan, et al.
Publicado: (2019)

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
por: Silva, Ygor Parladore, et al.
Publicado: (2020)

Association of epilepsy, anti-epileptic drugs (AEDs), and type 2 diabetes mellitus (T2DM): a population-based cohort retrospective study, impact of AEDs on T2DM-related molecular pathway, and via peroxisome proliferator-activated receptor γ transactivation
por: Tien, Ni, et al.
Publicado: (2023)

Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
por: Zhou, Ling, et al.
Publicado: (2020)

Roles of gut microbiota and metabolites in overweight and obesity of children
por: Zhang, Shengan, et al.
Publicado: (2022)

Potential role of 25(OH)D insufficiency in the dysfunction of glycolipid metabolism and cognitive impairment in patients with T2DM
por: Sun, Hui-min, et al.
Publicado: (2022)

The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
por: Zhang, Haiyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c9kacv70rju6pf1dltk4vnogfr